- Home
- PLTK vs TNGX Comparison
PLTK vs TNGX Comparison
Compare PLTK & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLTK | TNGX |
|---|---|---|
| Founded | 2010 | 2014 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | PLTK | TNGX |
|---|---|---|
| Price | $4.12 | $8.61 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 7 |
| Target Price | $6.61 | ★ $12.50 |
| AVG Volume (30 Days) | 954.0K | ★ 2.7M |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | ★ 9.80% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.23 | N/A |
| Revenue | ★ $2,726,900,000.00 | $66,501,000.00 |
| Revenue This Year | $9.52 | $53.01 |
| Revenue Next Year | $2.76 | N/A |
| P/E Ratio | $17.65 | ★ N/A |
| Revenue Growth | 7.49 | ★ 53.29 |
| 52 Week Low | $3.31 | $1.03 |
| 52 Week High | $7.58 | $11.20 |
Technical Indicators
Market Signals| Indicator | PLTK | TNGX |
|---|---|---|
| Relative Strength Index (RSI) | 51.26 | 42.32 |
| Support Level | $4.07 | $8.89 |
| Resistance Level | $4.42 | $10.08 |
| Average True Range (ATR) | 0.13 | 0.63 |
| MACD | -0.02 | -0.19 |
| Stochastic Oscillator | 27.38 | 3.14 |
Price Performance
Historical ComparisonAbout PLTK Playtika Holding Corp.
Playtika Holding Corp is engaged in developing mobile games. Some of its games include Board Kings, House of Fun, Poker Heat, Slotomania, and Bingo Blitz. The company has built live game operations services and a proprietary technology platform to support its portfolio of games. It derives revenue from the sale of virtual items associated with online games. Geographically, the group has a business presence in the USA, EMEA, APAC, and Other regions of which key revenue is derived from the USA. It offers both Mobile and Web-based platforms.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.